BGI Genomics: As of the end of July, a total of 167 million yuan has been spent to repurchase 1.10% of the company's shares.

The announcement from BGI Genomics states that the company plans to repurchase shares through a buyback scheme on June 16, 2026, with a total funding of 250 million to 500 million yuan and a repurchase price not exceeding 50 yuan per share, with an implementation period of 12 months. As of July 31, the company has cumulatively repurchased 4.6201 million shares, accounting for 1.1045% of the total share capital, with a maximum transaction price of 36.87 yuan per share and a minimum of 35.33 yuan per share, resulting in a total payment of 166.7 million yuan. The company will continue to buy back shares as planned and disclose updates in a timely manner.